SCHEMBL7779164

SCHEMBL7779164

C=CCn1nc(-c2ccc(S(C)(=O)=O)cc2)c(-c2ccc(OC)c(F)c2)c1C(F)(F)F

nearest known ligand 0.72

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 17/20 0.72
PTGS1 P23219 4/20 0.48
PI4KB Q9UBF8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7780037 0.93 PTGS2 (0.62) PTGS2PTGS1PI4KB
SCHEMBL7780867 0.92 PTGS2 (0.60) PTGS2PTGS1
SCHEMBL7780088 0.91 PTGS2 (0.69) PTGS2PTGS1
SCHEMBL7772990 0.89 PTGS2 (0.70) PTGS2PTGS1PI4KB
SCHEMBL7773317 0.88 PTGS2 (0.54) PTGS2PTGS1PI4KB
SCHEMBL7773202 0.88 PTGS2 (0.76) PTGS2PTGS1
SCHEMBL7779275 0.85 PTGS2 (0.79) PTGS2PTGS1
SCHEMBL7780026 0.85 PTGS2 (0.55) PTGS2PTGS1PI4KB
SCHEMBL7772890 0.85 PTGS2 (0.52) PTGS2PTGS1PI4KB
SCHEMBL7777334 0.85 PTGS2 (0.55) PTGS2PTGS1PI4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5756530-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G. D. SEARLE & CO. (US) 1998-05-26 US disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed